BORGIANI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 34.100
EU - Europa 2.630
AS - Asia 565
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 11
OC - Oceania 4
AF - Africa 3
Totale 37.330
Nazione #
US - Stati Uniti d'America 34.082
DE - Germania 450
UA - Ucraina 447
IE - Irlanda 367
IT - Italia 364
CN - Cina 335
FR - Francia 225
PL - Polonia 220
GB - Regno Unito 170
SE - Svezia 158
FI - Finlandia 101
KR - Corea 90
RU - Federazione Russa 56
BE - Belgio 28
KG - Kirghizistan 28
JP - Giappone 22
IR - Iran 18
NL - Olanda 16
TR - Turchia 13
CA - Canada 12
IN - India 12
VN - Vietnam 12
EU - Europa 11
HK - Hong Kong 8
UZ - Uzbekistan 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BR - Brasile 6
RO - Romania 6
MX - Messico 5
SG - Singapore 5
AU - Australia 3
BD - Bangladesh 3
CL - Cile 3
GR - Grecia 3
HU - Ungheria 3
IQ - Iraq 3
MA - Marocco 3
MY - Malesia 3
CH - Svizzera 2
IS - Islanda 2
PT - Portogallo 2
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 37.330
Città #
Woodbridge 9.831
Wilmington 9.461
Houston 8.577
Fairfield 1.197
Ann Arbor 737
Chandler 650
Ashburn 499
Seattle 430
Cambridge 389
Jacksonville 364
Dublin 339
New York 309
Medford 260
Kraków 215
Rome 170
Dearborn 159
Beijing 134
Lawrence 121
Menlo Park 94
San Diego 60
Redwood City 33
Milan 31
Zhengzhou 31
Palo Alto 30
Mülheim 27
Norwalk 26
Mountain View 23
Boardman 22
Brussels 21
Hefei 21
Shanghai 20
London 19
University Park 17
Seoul 15
Los Angeles 13
Helsinki 12
Nanjing 12
Detroit 11
Hangzhou 11
Kunming 11
Creede 10
Toronto 10
Hanoi 9
Verona 9
Nürnberg 8
Guangzhou 7
Hebei 7
Jinan 7
Kilburn 7
Saint Petersburg 7
San Mateo 7
Center 6
Fuzhou 6
Hong Kong 6
Indiana 6
Quzhou 6
Turhal 6
Waanrode 6
Changsha 5
Chiswick 5
Falls Church 5
Hounslow 5
Istanbul 5
Lappeenranta 5
Phoenix 5
Shenyang 5
Shenzhen 5
Atlanta 4
Auburn Hills 4
Chengdu 4
Chongqing 4
Islington 4
Livorno 4
Nanchang 4
New Bedfont 4
Novi Velia 4
San Francisco 4
Tappahannock 4
Abbadia San Salvatore 3
Anzio 3
Baotou 3
Budapest 3
Clearwater 3
Dhaka 3
Leawood 3
Padova 3
Perugia 3
Redmond 3
San Jose 3
Santa Clara 3
São Paulo 3
Taizhou 3
Wuhan 3
Ypsilanti 3
Albano Laziale 2
Amsterdam 2
Augusta 2
Baghdad 2
Bangalore 2
Buffalo 2
Totale 34.681
Nome #
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 454
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 453
CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population 436
High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase 435
Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians 428
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population 422
Advances in exploring the role of micrornas in inflammatory bowel disease 414
Age-related macular degeneration: insights into inflammatory genes 413
A Pharmacogenetics Study in Mozambican Patients Treated with Nevirapine: Full Resequencing of TRAF3IP2 Gene Shows a Novel Association with SJS/TEN Susceptibility 412
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 412
Intrauterine development and MNSs blood groups in repeated spontaneous abortion. 411
Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease 410
Interleukin-23R Arg381Gln Is Associated With Susceptibility to Crohn's Disease But Not With Phenotype in an Italian Population 409
Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice 406
Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01 405
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study 405
Foetal macrosomia and erythrocyte acid phosphatase (ACP1) polymorphism in diabetic and normal pregnancy. 405
Crohn's disease, the mycobacterium paratuberculosis and the genetic bond: An unexpected trio 405
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 404
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 402
Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms 399
Role of genetics in prevention of coronary atherosclerosis 399
Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype 399
Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction 397
Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient 397
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 397
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene 396
A family study of asymptomatic small bowel Crohn's disease 396
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development 395
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons syndrome/toxic epidermal necrolysis susceptibility in a population from Mozambique 393
FLG (filaggrin) null mutations and sunlight exposure: Evidence of a correlation 390
Cannabinoid Poisoning by Hemp Seed Oil in a Child 389
Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique 388
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 387
Association between ACP(1) and favism: A possible biochemical mechanism 386
Identification of two SNPs in the 5' flanking region of the ACP1 gene and evaluation of disequilibrium among polymorphic sites. 386
Neonatal screening, clinical features and genetic testing for galactosemia [3] 385
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase 383
Pharmacogenomics of multifactorial diseases: A focus on psoriatic arthritis 383
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis 380
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 380
Biomarkers to predict drug efficacy and safety in neurodegenerative diseases 379
A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus 378
Comparative analysis between saliva and buccal swabs as source of DNA: Lesson from HLA-B∗57:01 testing 377
Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome 375
EPHX1 Polymorphisms Are Not Associated With Warfarin Response in an Italian Population 374
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 374
Recent advances in the genetic susceptibility to osteoarthritis 373
Two molecular assays for the rapid and inexpensive detection of GJB2 and GJB6 mutations 373
Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy 372
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease 371
Association of the ACP1 genotype with metabolic parameters upon initial diagnosis of type 1 diabetes. 370
Genotyping OLR1 gene: A genomic biomarker for cardiovascular diseases 368
Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population 367
RH blood groups and diabetic disorders: Is there an effect on glycosylated hemoglobin level? 366
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 366
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. 365
MicroRNA genetic variations: association with type 2 diabetes 364
Diabetic complications and the genetics of signal transduction. A study of retinopathy in NIDDM 364
Correction: A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics 364
Phosphotyrosine-protein-phosphatase and diabetic disorders. Further studies on the relationship between low molecular weight acid phosphatase genotype and degree of glycemic control 362
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 359
A study of human growth hormone and insulin gene regions in relation to metabolic control of non-insulin-dependent diabetes mellitus 358
Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. 353
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 353
Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction 351
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 348
OLR1 gene and coronary artery disease/acute myocardial infarction: Replication in an independently collected sample [1] 347
Acid phosphatase locus 1 (ACP1): Possible relationship of allelic variation to body size and human population adaptation to thermal stress - A theoretical perspective 347
New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases [Nuovi approfondimenti nella ricerca su l'ateroslerosi: LOX-1, un primo attore nelle malattie cardiovascolari] 346
L’impatto sulla salute umana dell’arsenico presente in basse concentrazioni nelle acque. Proposta di uno studio caso controllo Nested nell’area del viterbese 346
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 346
Phosphoglucomutase genetic polymorphism of newborns 345
Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes 344
IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs 343
Rh blood groups and diabetic disorders 343
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 343
Pharmacogenomics: role in medicines approval and clinical use 342
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 341
ABCC10 rs2125739 polymorphism and nevirapine-induced hepatotoxicity: lack of association in a population from Mozambique 340
Genetic tests and genomic biomarkers: regulation, qualification and validation 340
Low molecular weight PTP-IL-4RA interaction in atopy predisposition 334
Foetal macrosomia in diabetic pregnancy. Further data on the association with maternal PGM1 genotype 333
Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility 312
Pharmacogenetics of inflammatory bowel disease: A focus on Crohn's disease 310
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 303
Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner. 292
Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic Studies 292
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 291
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population 269
Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility 266
A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine 253
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 239
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes 237
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects 231
Interaction between microbiome and host genetics in psoriatic arthritis 230
Pharmacogenomics in Parkinson's disease: which perspective for developing a personalized medicine? 223
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 209
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals 181
miRNAs in drug response variability: potential utility as biomarkers for personalized medicine 174
Totale 35.862
Categoria #
all - tutte 69.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.083 0 0 0 0 0 0 0 0 0 0 1.006 1.077
2019/202010.362 784 842 784 919 867 1.097 977 940 843 944 626 739
2020/20216.655 692 760 680 826 777 737 847 731 159 157 220 69
2021/20221.359 75 134 60 83 52 145 67 55 125 122 104 337
2022/20231.681 172 144 47 234 159 386 144 103 139 20 87 46
2023/2024667 87 20 41 26 50 338 34 41 12 9 9 0
Totale 37.802